Business Wire

DC-XYLEM

15.5.2023 13:31:33 CEST | Business Wire | Press release

Share
Water Operators Enabled to Cut CO2e Emissions by 2.8 Million Metric Tons, Using Xylem Technology

Global water technology company Xylem (NYSE: XYL) delivered significant progress towards its Sustainability Goals in 2022, including enabling water utilities to reduce their CO2e emissions by 2.8 million metric tons since 2019. Through its operations, supplier and sector-wide partnerships, and green finance offerings, Xylem aims to advance water security by reducing greenhouse gas (GHG) emissions, building watershed stewardship and resilience to climate change, and advancing equitable access to Water, Sanitation and Hygiene (WASH).

The results, captured in Xylem’s latest Sustainability Report, saw the company achieve its 2025 CO2e emissions reduction goal well ahead of schedule. The reduction was enabled by the deployment of high-efficiency technologies and digital solutions. Xylem also made notable progress in reducing its own emissions, with Scope 1 and Scope 2 emissions down 21% year-on-year, while also continuing to make strides on water and waste footprint reductions across its operations.

“The stakes have never been higher in our work to tackle the world’s water challenges,” Patrick Decker, President and CEO of Xylem, said. “As impacts from climate change intensify, water operators in utilities and businesses are leaning in to be part of the solution – embracing advanced technologies that improve the resiliency and sustainability of water systems at an affordable cost – all while lowering carbon emissions.”

“Our latest Sustainability Report captures the impact of this team effort. In partnership with our customers and communities, we are working towards making the water sector a leader in climate change mitigation while solving the world’s toughest water challenges,” Decker added.

With 2022 marking another record-setting year of severe weather events, Xylem also expanded its humanitarian support. As part of the Xylem Watermark program, employees volunteered 157,000 hours to address water, sustainability, and community challenges, an increase of 39% on 2021. The program’s initiatives included providing vital aid to communities in Ukraine and to earthquake-affected regions of Turkey.

“In 2022, we were proud to partner with our customers to support their exceptional strides towards creating more modern, resilient, and environmentally sensitive water systems,” said Claudia Toussaint, Xylem’s Chief People and Sustainability Officer. “The vision of our customers and the ingenuity and diversity of our teams have been instrumental in achieving these results. It allows us to look to the future with renewed optimism and ambition.”

Other key highlights detailed in the Sustainability Report include:

  • Executed a $1 billion credit facility that ties fees and interest rates to sustainability-related performance indicators, including emissions reduction.
  • Reduced total process water use by 26% since 2019 and moved 12 of its 22 major facilities to 100% process water recycling and reuse.
  • 88% of the electricity used at Xylem manufacturing, office, and service facilities came from renewable sources in 2022, an increase of 13% from 2021.
  • Onboarded over 600 suppliers to the WASH4Work pledge and included supply partners in community WASH projects since 2019.
  • Leveraged Xylem technology, solutions, and partnerships to mobilize aid for 30 areas impacted by disaster.
  • Provided WASH solutions to communities in need, reaching more than 2.4 million people.
  • Engaged 11,800 students through Xylem Ignite, the company’s youth program, with events including the Global Student Innovation Challenge, regional hackathons, and a six-month Innovation Incubator.

To learn more about Xylem’s sustainability progress, download the 2022 Sustainability Report.

*Refers to cars powered by internal combustion engine.

About Xylem

Xylem (XYL) is a leading global water technology company committed to solving critical water and infrastructure challenges with innovation. Our more than 17,000 diverse employees delivered revenue of $5.5 billion in 2022. We are creating a more sustainable world by enabling our customers to optimize water and resource management, and helping communities in more than 150 countries become water-secure. Join us at www.xylem.com.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

View source version on businesswire.com: https://www.businesswire.com/news/home/20230515005421/en/

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com
DK

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN26.10.2026 11:30:00 CET | Press release

Second limited-edition WHOOP x SR_A collection brings “performance for life” to new WHOOP bands, technical apparel, outerwear, and accessories designed for movement across city and rural environments. WHOOP, the human performance brand, today announced Layer 2 of PROJECT TERRAIN, its multiyear collaboration with British designer Samuel Ross MBE and his design atelier, SR_A. Building on the sold out debut collection launched in March 2026, Layer 2 expands PROJECT TERRAIN to its next season connecting lifestyle and performance for movement, adaptability and zone based training. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261026029587/en/ WHOOP and Samuel Ross MBE Unveil Layer 2 of PROJECT TERRAIN While the first PROJECT TERRAIN collection harnessed dense cities and modern training grounds, Layer 2 explores performance through material, silhouette and tactility. Drawing on the textures, conditions, and flux of the natural wo

Bleeding gums? Don't ignore the warning signs – the first stage of gum disease can be reversed26.10.2026 11:28:00 CET | Press release

Oral-B iO helps you avoid new tooth and gum issues—and if you have existing gum problems, it can resolve them quicker than a manual toothbrush. Gums bleeding when brushing can happen to any of us, and it is easy to ignore. But blood in the sink is a sign that something is not right with your mouth. Bleeding gums often indicate gingivitis, the earliest and most common form of gum disease. The good news: gingivitis can be reversed with proper oral hygiene. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20261022835650/en/ Oral-B iO Left untreated, gingivitis can progress into periodontitis, a more severe stage of gum disease that can only be managed, not reversed, and can lead to losing teeth over time. Healthy gums matter beyond the mouth, too. Oral health and systemic health are deeply interconnected, with inflammation and bacteria from oral diseases contributing to conditions such as heart disease, diabetes and dementia. "Gums

Merz Therapeutics Presents New Phase 2 PaiNT Data in Peripheral Neuropathic Pain at IASP 202626.10.2026 08:00:00 CET | Press release

Clinical and preclinical presentations reflect the company’s ongoing exploration of peripheral neuropathic pain Merz Therapeutics, a leading player in neurology-focused specialty pharma, today announced the presentation of new clinical and translational research in peripheral neuropathic pain (PNP) at the International Association for the Study of Pain (IASP) 2026 World Congress in Bangkok, Thailand, taking place from 26 to 30 October. The research spans new Phase 2 findings on incobotulinumtoxinA in postherpetic neuralgia (PHN) and post-surgical/post-traumatic neuropathic pain (PS/PTNP), as well as preclinical studies exploring potential biological mechanisms involved in effects of incobotulinumtoxinA on PNP models, highlighting Merz Therapeutics’ growing presence in neuropathic pain. In the PHN population of the Phase 2 PaiNT trial, results over 20 weeks favored incobotulinumtoxinA versus placebo treatment. In an exploratory analysis of average daily pain (ADP) intensity, the greates

Andersen Consulting tilføjer samarbejdsfirmaet TechSparq25.10.2026 06:09:00 CET | Pressemeddelelse

Andersen Consulting udvider sine kompetencer inden for teknologi og forretningstransformation gennem en samarbejdsaftale med TechSparq, en amerikansk virksomhed, der kombinerer strategi, commerce engineering og ai med praktisk implementering. TechSparq er et digitalt konsulenthus, der tilbyder strategi- og rådgivningstjenester, commerce engineering samt tjenester inden for ai og agentbaseret handel til virksomheder inden for detailhandel og forbrugsgoder, luksus og mode samt e-handel og direkte salg til forbrugere. Virksomheden har hovedkontor i Oregon og kombinerer strategisk planlægning med praktisk implementering for at hjælpe kunderne med at udvikle deres digitale initiativer, kundeoplevelse og driftsmodeller. "Vi etablerede vores virksomhed for at bygge bro mellem dem, der udvikler strategien, og dem, der har ansvaret for at føre den ud i livet," udtalte Dedrick Boyd, stifter af og administrerende direktør for TechSparq. "Vores samarbejde med Andersen Consulting giver os mulighed

BeOne Presents Compelling Data in Hard-to-Treat Liver and Lung Cancers at ESMO 202624.10.2026 10:15:00 CEST | Press release

Potential first-in-class GPC3 x 4-1BB bispecific achieves a 36% confirmed response rate at Phase 3 dose and favorable safety profile in heavily pretreated liver cancerBrain-penetrant PRMT5 inhibitor shows promising antitumor and CNS activity in the largest publicly shared MTAP-deficient datasetFirst clinical data of CEA-targeting ADC demonstrates encouraging and sustained responses in CEAhigh NSCLC BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced new data from multiple differentiated investigational medicines across its priority solid tumor disease areas at the European Society for Medical Oncology (ESMO) Congress 2026 (October 23–27, Madrid). The presentations span gastrointestinal, lung, and breast cancers, and reflect the growing momentum of BeOne’s solid tumor franchise. Mark Lanasa, M.D., Ph.D., Chief Medical Officer, Solid Tumors at BeOne, said: “At ESMO, we are showing how our strategy of matching the right modality to dise

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye